Nasdaq

Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests ("2.0") under CE Mark for self-test and professional use

Broad and trusted portfolio of COVID-19 rapid tests feature innovative updates and enhanced performance, building on insights gained throughout the pandemic All tests now work seamlessly with navify® ...
Nasdaq

Roche to launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in countries accepting the CE Mark to enable rapid differentiation of viral respiratory infections

Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...
ad-hoc-news

Roche Diagnostics Corona Test: Why This Covid Test Still Matters More Than You Think

Roche Diagnostics (Corona Test) turns the anxiety of "Do I have Covid?" into clear, lab?grade answers you can actually trust. In a crowded market of quick tests and mixed results, Roche leans on ...
The Indianapolis Star

Is it COVID, the flu, or RSV? A Roche test could soon provide the answer in 20 minutes

This past winter, hospitals and clinics across Indiana filled up with patients suffering from different respiratory illnesses that have much the same symptoms: COVID-19, flu and RSV. And many more ...
Yahoo Finance

Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization

The test uses highly sensitive PCR technology, requiring only a single nasal-swab sample to provide rapid, accurate qualitative detection and differentiation among four of the most prevalent ...
Reuters

Roche to make hundreds of millions of COVID-19 rapid tests monthly - CEO

ZURICH, Oct 29 (Reuters) - Swiss drugmaker Roche plans to boost production of rapid COVID-19 tests to hundreds of millions monthly, including possible saliva tests, Chief Executive Severin Schwan said ...